TRC150094 attenuates progression of nontraditional cardiovascular risk factors associated with obesity and type 2 diabetes in obese ZSF1 rats
Shitalkumar P Zambad1, Siralee Munshi2, Amita Dubey3, Ram Gupta1, Rosa Anna Busiello4, Antonia Lanni5, Fernando Goglia6, Ramesh C Gupta7, Vijay Chauthaiwale8, Chaitanya Dutt91Pharmacology, 2Cellular and Molecular Biology, 3Pre-clinical and Safety Evaluation, Torrent Research Centre, Torrent Pharmace...
Guardado en:
Autores principales: | Shitalkumar P Zambad, Siralee Munshi, Amita Dubey, et al |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e84565ddb2e642eea6cb0aa11386a7cd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity
por: Zambad SP, et al.
Publicado: (2013) -
Prolylcarboxypeptidase (PRCP) as a new target for obesity treatment
por: B Shariat-Madar, et al.
Publicado: (2010) -
Abdominal obesity: causal factor or simply a symptom of obesity-related health risk
por: Oh S, et al.
Publicado: (2014) -
Association of lipid profile and waist circumference as cardiovascular risk factors for overweight and obesity among school children in Qatar
por: Rizk NM, et al.
Publicado: (2012) -
Imaging body composition in obesity and weight loss: challenges and opportunities
por: Heidi J Silver, et al.
Publicado: (2010)